Cite
Friman S, Tisone G, Nevens F, et al. Long-term, Prolonged-release Tacrolimus-based Immunosuppression in De Novo Liver Transplant Recipients: 5-year Prospective Follow-up of Patients in the DIAMOND Study. Transplant Direct. 2021;7(8):e722doi: 10.1097/TXD.0000000000001166.
Friman, S., Tisone, G., Nevens, F., Lehner, F., Santaniello, W., Bechstein, W. O., Zhuvarel, S. V., Isoniemi, H., Rummo, O. O., Klempnauer, J., Anaokar, S., Hurst, M., Kazeem, G., Undre, N., & Trunečka, P. (2021). Long-term, Prolonged-release Tacrolimus-based Immunosuppression in De Novo Liver Transplant Recipients: 5-year Prospective Follow-up of Patients in the DIAMOND Study. Transplantation direct, 7(8), e722. https://doi.org/10.1097/TXD.0000000000001166
Friman, Styrbjörn, et al. "Long-term, Prolonged-release Tacrolimus-based Immunosuppression in De Novo Liver Transplant Recipients: 5-year Prospective Follow-up of Patients in the DIAMOND Study." Transplantation direct vol. 7,8 (2021): e722. doi: https://doi.org/10.1097/TXD.0000000000001166
Friman S, Tisone G, Nevens F, Lehner F, Santaniello W, Bechstein WO, Zhuvarel SV, Isoniemi H, Rummo OO, Klempnauer J, Anaokar S, Hurst M, Kazeem G, Undre N, Trunečka P. Long-term, Prolonged-release Tacrolimus-based Immunosuppression in De Novo Liver Transplant Recipients: 5-year Prospective Follow-up of Patients in the DIAMOND Study. Transplant Direct. 2021 Jul 09;7(8):e722. doi: 10.1097/TXD.0000000000001166. eCollection 2021 Aug. PMID: 34263020; PMCID: PMC8274734.
Copy
Download .nbib